Books > Medicine > Clinical & internal medicine > Ophthalmology
|
Buy Now
Metipranolol - Pharmacology of Beta-blocking Agents and Use of Metipranolol in Ophthalmology (Paperback)
Loot Price: R1,503
Discovery Miles 15 030
|
|
Metipranolol - Pharmacology of Beta-blocking Agents and Use of Metipranolol in Ophthalmology (Paperback)
Expected to ship within 10 - 15 working days
|
After a compound and its various effects - or, as the case may be,
any particular one of these - have been discovered there is still a
long way ahead until it is available for use in daily practice as a
finished product. Before reaching the doctor, the substance is
examined by chemists, pharmacologists and pharmacists - just to
mention a few of the most important stages in a whole research
sequence. Before the drug is finally made available on the market,
the findings resulting from animal experiments must be confirmed in
clinical studies. The expectations involved in its development must
be met, and sufficient evidence has to be established as to the
drug's effects and side effects, indications and contraindications,
and the questions of safe use and appropriate dosage. Only then may
the drug be registered and introduced to the market. In this
respect Metipranolol eye drops, which have recently been launched
on the market, formed no exception and had likewise to go through
all these various stages. A series of investigators at many
different centers participated in this procedure, and at the
invitation of the manufacturers, Messrs. Dr. Gerhard Mann, they
assembled for discussions at a symposium held in Berlin in January
1983, and reported on the substance and their experiences with it.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.